ArticleCancer management and research2021

First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations with Postoperative Intrapulmonary Recurrence.

Zhouyu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.